Subspecialties: Page 1273

J&J to appeal Boston Scientific stent ruling

By AuntMinnie.com staff writers

Johnson & Johnson subsidiary Biologics Delivery Systems Group, Cordis of Miami Lakes, FL, said it will appeal yesterday's decision by a U.S. District Court judge upholding a jury finding last year in Wilmington, DE, in favor of interventional device firm Boston Scientific on stent patents.

June 15, 2006

Lung CAD may lead radiologists down the wrong path

By Eric Barnes

SAN FRANCISCO - One thing seems certain as lung computer-aided detection (CAD) systems move increasingly into clinical use: radiologists find more potentially malignant nodules with CAD than without it. But could CAD also be a case of too much of a good thing?

June 15, 2006

Boston Scientific wins J&J patent appeal

By AuntMinnie.com staff writers

Interventional device firm Boston Scientific of Natick, MA, reported that the U.S. District Court in Delaware issued a ruling upholding a July 2005 jury verdict in a patent case against Johnson & Johnson (J&J).

June 15, 2006

VC software highlights colon's unseen areas

By Eric Barnes

A new virtual colonoscopy software application aims to eliminate the problem of missed areas on endoluminal fly-throughs by highlighting spots that were missed during the first two fly-throughs, so they can be examined in a third look. A video clip shows you how it's done.

June 15, 2006

FDA issues gadolinium health advisory

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration has issued a health advisory regarding MRI contrast agents containing gadolinium after two dozen cases of a rare disease that developed in European patients following administration of a gadolinium-based agent.

June 14, 2006

Assessing patient risk will help prevent contrast-induced nephropathy

By Wayne Forrest

SAN FRANCISCO - With the increasing use of contrast media, contrast-induced nephropathy (CIN) is becoming a more critical issue for radiologists, cardiologists, and nephrologists. At this week's International Symposium on Multidetector-Row CT, physicians debated the most appropriate steps to prevent CIN, which patients are most at-risk, and the efficacy of low- and iso-osmolar contrast media in reducing incidents of CIN.

June 14, 2006